Rachel Kuperman

Eysz, Inc. is a startup based in an undisclosed location that is developing a digital health platform to enable personalized medicine for neurological disorders, starting with epilepsy. Eysz's unique AI-based software analyzes passive eye-movements from compatible eye-tracking systems to assist clinicians in understanding their patients' seizure burden and neurocognitive side effects, enabling them to create a more personalized care plan. This could potentially result in better quality of life, improved treatment adherence, and lower costs for patients with epilepsy. The American company was founded by Jit Sarkar, Rachel Kuperman, and Parth Amin, with Rachel Kuperman serving as the CEO since incorporation.